Polypharmacy and risk of admission to hospital in people ageing with HIV: what is the contribution of drug–drug interactions?

Bibliographic Details
Main Authors:	Clotilde Allavena, Catia Marzolini
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Series:	The Lancet. Healthy Longevity
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666756821002270

id	doaj-72c46a452b234c61aa864467b7ffed37
record_format	Article
spelling	doaj-72c46a452b234c61aa864467b7ffed372021-10-01T05:12:25ZengElsevierThe Lancet. Healthy Longevity2666-75682021-10-01210e606e607Polypharmacy and risk of admission to hospital in people ageing with HIV: what is the contribution of drug–drug interactions?Clotilde Allavena0Catia Marzolini1Department of Infectious Diseases, Hôtel Dieu CHU Nantes, INSERM UIC 1413, FranceDivision of Infectious Diseases and Hospital Epidemiology, Department of Medicine and Department of Clinical Research, University Hospital of Basel and University of Basel, Switzerland; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, UKhttp://www.sciencedirect.com/science/article/pii/S2666756821002270
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Clotilde Allavena Catia Marzolini
spellingShingle	Clotilde Allavena Catia Marzolini Polypharmacy and risk of admission to hospital in people ageing with HIV: what is the contribution of drug–drug interactions? The Lancet. Healthy Longevity
author_facet	Clotilde Allavena Catia Marzolini
author_sort	Clotilde Allavena
title	Polypharmacy and risk of admission to hospital in people ageing with HIV: what is the contribution of drug–drug interactions?
title_short	Polypharmacy and risk of admission to hospital in people ageing with HIV: what is the contribution of drug–drug interactions?
title_full	Polypharmacy and risk of admission to hospital in people ageing with HIV: what is the contribution of drug–drug interactions?
title_fullStr	Polypharmacy and risk of admission to hospital in people ageing with HIV: what is the contribution of drug–drug interactions?
title_full_unstemmed	Polypharmacy and risk of admission to hospital in people ageing with HIV: what is the contribution of drug–drug interactions?
title_sort	polypharmacy and risk of admission to hospital in people ageing with hiv: what is the contribution of drug–drug interactions?
publisher	Elsevier
series	The Lancet. Healthy Longevity
issn	2666-7568
publishDate	2021-10-01
url	http://www.sciencedirect.com/science/article/pii/S2666756821002270
work_keys_str_mv	AT clotildeallavena polypharmacyandriskofadmissiontohospitalinpeopleageingwithhivwhatisthecontributionofdrugdruginteractions AT catiamarzolini polypharmacyandriskofadmissiontohospitalinpeopleageingwithhivwhatisthecontributionofdrugdruginteractions
_version_	1716862094534508544

Polypharmacy and risk of admission to hospital in people ageing with HIV: what is the contribution of drug–drug interactions?

Similar Items